Executive Director, Worldwide Medical Affairs Disease Area Head GI/GU Cancers

Working with Us
Challenging. Meaningful. Life-changing. Those aren’t words that are usually associated with a job. But working at Bristol Myers Squibb is anything but usual. Here, uniquely interesting work happens every day, in every department. From optimizing a production line to the latest breakthroughs in cell therapy, this is work that transforms the lives of patients, and the careers of those who do it. You’ll get the chance to grow and thrive through opportunities uncommon in scale and scope, alongside high-achieving teams rich in diversity. Take your career farther than you thought possible.

Bristol Myers Squibb recognizes the importance of balance and flexibility in our work environment. We offer a wide variety of competitive benefits, services and programs that provide our employees with the resources to pursue their goals, both at work and in their personal lives. Read more: careers.bms.com/working-with-us.

Position Summary:

We are seeking a dynamic and visionary Worldwide Medical Affairs Disease Area Head (WW-DAH) to oversee our Oncology Worldwide GI, GU Cancers programs. This pivotal role involves shaping and executing the global medical strategy for these disease areas, ensuring scientific excellence, and driving the development of life-changing therapies for patients worldwide. The WW-DAH will collaborate closely with cross-functional teams, including Research & Development, Commercial, and Market Access, to maximize the value of our oncology portfolio and will report to the SVP, Head of Worldwide Medical Affairs Oncology.

Key Responsibilities:

• Strategic Leadership:

  • Develop and execute the global medical strategy for GI, GU cancers, aligning with organizational goals and patient needs.

  • Anticipate and respond to dynamic market landscapes, including scientific, regulatory, and competitive challenges, ensuring a leadership position in the global oncology market.

  • Collaborate with R&D, Commercial, and Market Access teams to shape pipeline and portfolio strategies that deliver life-changing therapies to patients.

• Portfolio Impact and Innovation:

  • Identify unmet needs, market trends, and opportunities for new product development or acquisitions in GI, GU cancers.

  • Oversee differentiation strategies and signal-seeking initiatives to expand the pipeline and identify transformative therapeutic opportunities.

  • Shape early development strategy and contribute to trial designs and recruitment.

  • Ensure appropriate access for patients across US and international markets.

•  Team Accountability:

  • Oversee the Medical Product Leads (MPL) and AIMs (Asset Integrated Medical Teams) to ensure strategy is co-created with the markets and that asset strategies reflect the needs of our countries while driving top market performance and support.

  • Serve as the key medical representative on the brand team and Global Product Teams, providing strategic leadership and scientific expertise.

  • Medical partner on the disease area/Tumor strategy team and brand strategy team

• Medical Evidence Generation:

  • Collaborate with cross-functional teams to ensure evidence generation efforts support regulatory submissions, reimbursement decisions, and market access strategy.

  • Responsible for the Disease area Evidence generation strategies; accountable for the integrated evidence plans and prioritize studies to address key stakeholders' needs, including patients, healthcare providers, and payors.

  • Oversee the design and implementation of interventional trials and real-world evidence (RWE) studies, including early signal-seeking studies, investigator-sponsored research (ISR), medical affairs-led studies, post-market studies, registries, and observational research.

• Operational Excellence and Outcomes:

  • Lead a high-performing, inclusive, and diverse team of medical and scientific professionals, fostering a culture of accountability, collaboration, and empowerment to achieve exceptional results.

  • Champion organizational efficiency and agility by implementing streamlined processes that enable seamless global execution of strategic programs, initiatives, and high-impact launches.

  • Leverage advanced digital capabilities and data-driven tools to optimize decision-making, enhance stakeholder engagement, and provide actionable insights that shape medical and business strategies.

  • E